Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ouro Medicines

Clinical trials sponsored by Ouro Medicines, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody drug targets autoimmune diseases in early trial Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New antibody drug targets autoimmune diseases in early trial

Disease control Recruiting now

This early-phase study tests a new drug called OM336 in 39 adults with active Sjogren's disease or idiopathic inflammatory myopathy who have not improved with at least two prior treatments. OM336 is an engineered antibody designed to target and potentially reduce harmful immune c…

Phase 1 • Sponsor: Ouro Medicines • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC